Dana-Farber’s quarterly revenue climbs to $487M: 4 things to know

Boston-based Dana-Farber Cancer Institute’s revenue climbed 11.5 percent year over year to $487.2 million in the first quarter of fiscal year 2019, according to financial documents released March 13.

Advertisement

Four things to know:

1. Hospital management said the increase in revenue was largely attributable to growth in patient volume and higher pharmacy revenue.

2. During the first three months of fiscal 2019, Dana-Farber’s operating expenses climbed to $454.4 million, an increase of 12.7 percent over the same period of fiscal 2018.

3. Dana-Farber ended the first quarter of fiscal 2019 with operating income of $32.8 million, compared to operating income of $33.8 million in the first quarter of fiscal 2018.

4. After factoring in a $31.6 million investment loss, Dana-Farber recorded a net loss of $1.2 million in the first three months of fiscal 2019. That’s compared to the first quarter of fiscal 2018, when the hospital recorded net income of $46.1 million.

More articles on healthcare finance:

Quorum aims to shed up to 9 hospitals
North Carolina agrees to increase reimbursement rates for rural hospitals
14 recent hospital, health system outlook and credit rating actions

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.